0001213900-21-026675.txt : 20210517
0001213900-21-026675.hdr.sgml : 20210517
20210517073156
ACCESSION NUMBER: 0001213900-21-026675
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190415
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weisblum Eric
CENTRAL INDEX KEY: 0001569077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-54872
FILM NUMBER: 21927562
MAIL ADDRESS:
STREET 1: 285 GRAND AVENUE
CITY: ENGLEWOOD
STATE: NJ
ZIP: 07631
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Silo Pharma, Inc.
CENTRAL INDEX KEY: 0001514183
STANDARD INDUSTRIAL CLASSIFICATION: APPAREL & OTHER FINISHED PRODS OF FABRICS & SIMILAR MATERIAL [2300]
IRS NUMBER: 462137136
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 560 SYLVAN AVE
STREET 2: SUITE 3160
CITY: ENGLEWOOD CLIFFS
STATE: NJ
ZIP: 07632
BUSINESS PHONE: (718) 400-9031
MAIL ADDRESS:
STREET 1: 560 SYLVAN AVE
STREET 2: SUITE 3160
CITY: ENGLEWOOD CLIFFS
STATE: NJ
ZIP: 07632
FORMER COMPANY:
FORMER CONFORMED NAME: Uppercut Brands, Inc.
DATE OF NAME CHANGE: 20190808
FORMER COMPANY:
FORMER CONFORMED NAME: Point Capital, Inc.
DATE OF NAME CHANGE: 20130130
FORMER COMPANY:
FORMER CONFORMED NAME: Gold Swap Inc
DATE OF NAME CHANGE: 20110301
4
1
ownership.xml
X0306
4
2019-04-15
0
0001514183
Silo Pharma, Inc.
SILO
0001569077
Weisblum Eric
C/O SILO PHARMA, INC.
560 SYLVAN AVE., SUITE 3160
ENGLEWOOD CLIFFS
NJ
07632
1
1
0
0
CEO, CFO and President
Common Stock
2019-06-17
4
P
0
57714
0.002
A
57714
D
Common Stock
2019-10-15
4
P
0
200
0.38
A
57914
D
Common Stock
2019-10-22
4
P
0
200
0.45
A
58114
D
Stock Option (right to buy)
0.0001
2019-04-15
4
A
0
100000
0
A
2019-04-15
2024-04-15
Common Stock
100000
100000
D
Stock Option (right to buy)
0.0001
2019-04-15
4
A
0
100000
0
A
2019-07-15
2024-07-15
Common Stock
100000
100000
D
Stock Option (right to buy)
0.0001
2019-10-15
4
A
0
100000
0
A
2019-10-15
2024-10-15
Common Stock
100000
100000
D
The options were granted pursuant to the Employment Agreement by and between the Issuer and the Reporting Person dated April 15, 2019.
The options were granted on April 15, 2019 and vested in full on July 15, 2019.
/s/ Eric Weisblum
2021-05-17